🇺🇸 FDA
Patent

US 7485440

Production of attenuated respiratory syncytial virus vaccines involving modification of M2 ORF2

granted A61KA61K2039/5254A61K2039/543

Quick answer

US patent 7485440 (Production of attenuated respiratory syncytial virus vaccines involving modification of M2 ORF2) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Jan 29 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Feb 03 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 29 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K2039/5254, A61K2039/543, A61K2039/544, A61K39/12